Javascript must be enabled to continue!
Adrenocortical hypofunction with simultaneous primary aldosteronism
View through CrossRef
Abstract
Rationale:
Cases of adrenocortical hyperfunction combined with primary aldosteronism have been reported in the literature, and the underlying mechanism involves the secretion of aldosterone and glucocorticoids by a tumor or an adenoma. However, adrenocortical hypofunction and coexisting primary aldosteronism have not been reported until now. Herein, we report a case of adrenocortical hypofunction combined with primary aldosteronism.
Patient concerns:
A 66-year-old Chinese woman with rheumatoid arthritis who had been diagnosed with secondary adrenal insufficiency and was taking prednisone acetate tablets for replacement treatment presented to our department. She also had type 2 diabetes mellitus, osteoporosis, bilateral knee osteoarthritis, and lumbar vertebral compression fracture. She had previously developed tuberculosis, which had been cured.
Diagnosis:
The cortisol and adrenocorticotropic hormone rhythm indicated cortisol dysfunction in the patient. A 64-slice computed tomography and magnetic resonance imaging both showed bilateral adrenal hyperplasia. A postural stimulation test indicated a high level of aldosteronism and a high aldosterone-to-renin ratio (ARR, supine position: aldosterone 1788.73 pg/mL, ARR 146.62; upright position: aldosterone 2916.21 pg/mL, ARR 92.29). The captopril test showed the aldosterone level decreased by 364.70 pg/mL 1 hour after administration of captopril (from 2153.28 to 1788.58 pg/mL). The decline in aldosterone level was approximately 16.90% (i.e., <30%), and the ARR was still >40. Based on the above-mentioned findings, we diagnosed the patient with adrenocortical hypofunction with primary aldosteronism.
Interventions:
We administered spironolactone 20 mg twice daily and continued the glucocorticoid replacement therapy.
Outcomes:
One week after diagnosis, the patient had an aldosterone level of 2201.16 pg/mL, plasma renin activity of 3.88 ng/mL/h, and an ARR of 56.7 (upright position). Her blood pressure was maintained within the normal range.
Lessons:
Although adrenocortical hypofunction with primary aldosteronism is rare, cases of primary aldosteronism complicated with hypercortisolism are occasionally encountered. Hence, whenever possible, we recommend testing both aldosterone and cortisol levels in all patients with adrenal dysfunction.
Ovid Technologies (Wolters Kluwer Health)
Title: Adrenocortical hypofunction with simultaneous primary aldosteronism
Description:
Abstract
Rationale:
Cases of adrenocortical hyperfunction combined with primary aldosteronism have been reported in the literature, and the underlying mechanism involves the secretion of aldosterone and glucocorticoids by a tumor or an adenoma.
However, adrenocortical hypofunction and coexisting primary aldosteronism have not been reported until now.
Herein, we report a case of adrenocortical hypofunction combined with primary aldosteronism.
Patient concerns:
A 66-year-old Chinese woman with rheumatoid arthritis who had been diagnosed with secondary adrenal insufficiency and was taking prednisone acetate tablets for replacement treatment presented to our department.
She also had type 2 diabetes mellitus, osteoporosis, bilateral knee osteoarthritis, and lumbar vertebral compression fracture.
She had previously developed tuberculosis, which had been cured.
Diagnosis:
The cortisol and adrenocorticotropic hormone rhythm indicated cortisol dysfunction in the patient.
A 64-slice computed tomography and magnetic resonance imaging both showed bilateral adrenal hyperplasia.
A postural stimulation test indicated a high level of aldosteronism and a high aldosterone-to-renin ratio (ARR, supine position: aldosterone 1788.
73 pg/mL, ARR 146.
62; upright position: aldosterone 2916.
21 pg/mL, ARR 92.
29).
The captopril test showed the aldosterone level decreased by 364.
70 pg/mL 1 hour after administration of captopril (from 2153.
28 to 1788.
58 pg/mL).
The decline in aldosterone level was approximately 16.
90% (i.
e.
, <30%), and the ARR was still >40.
Based on the above-mentioned findings, we diagnosed the patient with adrenocortical hypofunction with primary aldosteronism.
Interventions:
We administered spironolactone 20 mg twice daily and continued the glucocorticoid replacement therapy.
Outcomes:
One week after diagnosis, the patient had an aldosterone level of 2201.
16 pg/mL, plasma renin activity of 3.
88 ng/mL/h, and an ARR of 56.
7 (upright position).
Her blood pressure was maintained within the normal range.
Lessons:
Although adrenocortical hypofunction with primary aldosteronism is rare, cases of primary aldosteronism complicated with hypercortisolism are occasionally encountered.
Hence, whenever possible, we recommend testing both aldosterone and cortisol levels in all patients with adrenal dysfunction.
Related Results
Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit
Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit
Introduction:
Primary aldosteronism is the most frequent cause of hypertension although is undetected. The 2016 Endocrine Society guidelines (2016-ESG) recommendations ...
Relationship Between Corrective Saccades and Measures of Physical Function in Unilateral and Bilateral Vestibular Loss
Relationship Between Corrective Saccades and Measures of Physical Function in Unilateral and Bilateral Vestibular Loss
Objectives:
Following the loss of vestibular function, some patients functionally improve and are minimally bothered by their loss of peripheral function while others r...
Resistant Hypertension Due to Primary Aldosteronism - A Case Report
Resistant Hypertension Due to Primary Aldosteronism - A Case Report
By definition, resistant hypertension means blood pressure that remains above the goal inspite of concurrent use of three antihypertensive drugs of different classes, of which one ...
ENDOCRINE TUMOURS: The genomics of adrenocortical tumors
ENDOCRINE TUMOURS: The genomics of adrenocortical tumors
The last decade witnessed the emergence of genomics, a set of high-throughput molecular measurements in biological samples. These pan-genomic and agnostic approaches have revolutio...
Oncocytic Variant of Adrenocortical Carcinoma: Case Report of a Rare Malignancy
Oncocytic Variant of Adrenocortical Carcinoma: Case Report of a Rare Malignancy
Adrenocortical carcinoma is a rare cancer. Oncocytic tumors of the adrenal gland are rarer. Most Oncocytic
Adrenal Neoplasms are benign and carry favourable prognosis. They are cla...
Adrenocortical Causes of Hypertension
Adrenocortical Causes of Hypertension
Primary aldosteronism is the most common cause of secondary hypertension. In the past, screening for primary aldosteronism was offered only in patients with hypertension associated...
Data from Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
Data from Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
<div>Abstract<p><b>Purpose:</b> Our understanding of adrenocortical carcinoma (ACC) has improved considerably, yet many unanswered questions remain. For ins...
Data from Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
Data from Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
<div>Abstract<p><b>Purpose:</b> Our understanding of adrenocortical carcinoma (ACC) has improved considerably, yet many unanswered questions remain. For ins...

